Viewing Study NCT00601159


Ignite Creation Date: 2025-12-24 @ 2:45 PM
Ignite Modification Date: 2026-03-02 @ 4:06 AM
Study NCT ID: NCT00601159
Status: COMPLETED
Last Update Posted: 2011-07-04
First Post: 2007-12-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module